Norway to buy Biogen’s Spinraza medicine: broadcaster NRK OSLO – Norwegian government bodies will choose the rare-disease treatment Spinraza for individuals from U http://lotrel.net/dosage .S. Drugmaker Biogen Inc at a price of 7 million Norwegian crowns each year per individual, open public broadcaster NRK reported on Mon. FILE Image: An indicator marks a Biogen facility in Cambridge, Massachusetts, U.S. 26 january, 2017. REUTERS/Brian Snyder/Document PhotoSpinraza goodies the rare, frequently fatal disease vertebral muscular atrophy . Norwegian specialists covers the expenses for minors just.